FIELD: biotechnology.
SUBSTANCE: antibody to PD-1, its antigen-binding fragment, a pharmaceutical composition containing an antibody to PD-1 and its antigen-binding fragment, a nucleic acid molecule encoding an antibody to PD-1 or its antigen-binding fragment. In particular, a host cell for producing an antibody to PD-1 or an antigen-binding fragment thereof and a method for treating diseases associated with PD-1 are proposed.
EFFECT: used for the treatment of cancer.
20 cl, 3 dwg, 21 tbl, 7 ex
| Title |
Year |
Author |
Number |
| ANTIBODY TO PD-L1, ITS ANTIGEN-BINDING FRAGMENT, AND THEIR PHARMACEUTICAL USE |
2019 |
- Gu, Xiaoling
- Jiang, Jiahua
- Zhang, Lei
- Hu, Qiyue
- Gu, Jinming
- Tao, Weikang
|
RU2778085C2 |
| PHARMACEUTICAL COMPOSITION BASED ON ANTIBODY TO PD-L1 AND ITS APPLICATION |
2018 |
- Yan, Zhen
- Yang, Jianjian
- Yan, Xiaodan
- Wu, Shan
- Liu, Xun
|
RU2766590C2 |
| FUSED PROTEIN CONTAINING TGF-BETA RECEPTOR, AND ITS PHARMACEUTICAL USE |
2018 |
- Gu, Tszinmin
- Lo, Syao
- Tao, Vejkan
|
RU2776204C1 |
| PHARMACEUTICAL COMPOSITION OF THE FUSION PROTEIN OF THE TRANSFORMING GROWTH FACTOR BETA RECEPTOR AND ITS APPLICATION |
2019 |
- Tyan, Chenmin
- Li, Khao
- Lyu, Syun
|
RU2791683C2 |
| CONNECTIVE TISSUE GROWTH FACTOR ANTIBODY AND USE THEREOF |
2020 |
- Fu, Yayuan
- Ma, Syaoli
- Ge, Khu
- Tao, Vejkan
|
RU2819228C2 |
| ANTI-CLAUDIN 18.2 ANTIBODY AND USE THEREOF |
2020 |
- Yan, Yan
- Ge, Khu
- Tao, Vejkan
|
RU2822550C2 |
| ANTIBODY TO CD3 AND ITS PHARMACEUTICAL USE |
2019 |
- Ying Hua
- Zhang Ling
- Yang Xiaoying
- Ge Hu
- Tao Weikang
|
RU2802272C2 |
| ANTIBODY AGAINST IL-5, ITS ANTIGEN-BINDING FRAGMENT AND ITS MEDICAL USE |
2018 |
- In, Khua
- Shi, Tszinpin
- Van, Ifan
- Khu, Tsiyue
- Ge, Khu
- Tao, Vejkan
|
RU2772716C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ANTIBODIES TO PCSK-9, AND ITS USE |
2018 |
- Tian, Chenmin
- Li, Hao
- Liu, Xun
|
RU2782792C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ANTIBODY TO LAG-3 AND ITS USE |
2018 |
- Wu Tingting
- Li Hao
- Liu Xun
- Fu Yayuan
|
RU2771384C2 |
